SCHEMBL23014180

SCHEMBL23014180

C#CCCCN(c1cc(OC)c(Cl)cc1OC)S(=O)(=O)c1ccc(OCC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
TSHR P16473 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
KEAP1 Q14145 3/20 0.40
NFE2L2 Q16236 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 3/20 0.39
THRB P10828 1/20 0.39
HTT P42858 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HCRTR2 O43614 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23014221 0.95 ALDH1A1 (0.51) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014633 0.89 ALDH1A1 (0.47) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014191 0.88 ALDH1A1 (0.44) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014627 0.88 ALDH1A1 (0.47) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014224 0.87 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014520 0.87 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014634 0.87 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014067 0.87 KEAP1 (0.46) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL23014638 0.87 L3MBTL1 (0.50) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL23014063 0.86 ALDH1A1 (0.45) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220305121-A1 N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-09-29 US disclosed
WO-2021034729-A1 N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220305121-A1 N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANT TLR1, TLR3, TLR2 ALDH1A1 4133/4885TSHR 2287/4885CYP3A4 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.